Sun Corporation's Trading Barely Breaks Even; Its ¥1,500 Million Quarterly Profit Comes From Cellebrite

Sales barely moved, and the operating line barely registered

Sun Corporation (TSE: 6736) published consolidated results for the three months to June 30, 2026 on August 10, 2026 under Japanese GAAP. The group describes its management policy as a concentration on information and communications — security and M2M/IoT — and on entertainment, meaning pachinko and pachislot machines and games, and it reports across four segments. Net sales fell 0.3% to ¥2,578 million from ¥2,585 million, a decline of ¥6 million. Gross profit nonetheless rose 21.1% to ¥761 million from ¥629 million, and although selling, general and administrative expenses rose ¥48 million to ¥768 million, the operating loss narrowed to ¥6 million from ¥90 million. Ordinary profit then fell 78.6% to ¥384 million, and profit attributable to owners of the parent 15.5% to ¥1,500 million, for basic earnings per share of ¥69.72 against ¥79.74 and diluted earnings per share of ¥69.64 against ¥79.66. Comprehensive income was ¥2,172 million, up 192.0%.

Cellebrite made the profit, and Cellebrite unmade it

The distance between a ¥6 million operating loss and ¥1,500 million of net profit is entirely non-operating, and the filing names the cause on both sides of it. Non-operating income of ¥404 million was mostly ¥364 million of equity-method investment income from Cellebrite, an affiliate accounted for under the equity method — and that line was ¥1,463 million smaller than a year earlier, when it stood at ¥1,828 million. That single item is why ordinary profit fell ¥1,415 million, from ¥1,800 million to ¥384 million. Interest and dividends received contributed ¥30 million and non-operating expenses were ¥13 million. Below ordinary profit the company booked a ¥1,121 million gain on the change in its equity interest in Cellebrite as an extraordinary gain — the accounting gain that arises when an affiliate issues shares and the holder's percentage interest moves — taking pre-tax profit to ¥1,506 million. Income taxes of only ¥5 million, against ¥24 million a year earlier, left net profit at ¥1,500 million. In short, the trading businesses ran at roughly break-even and the reported profit is the affiliate.

The balance sheet is mostly one shareholding

Total assets rose 2.8% to ¥55,141 million from ¥53,652 million at March 31, 2026, and the increase is essentially one line: shares of affiliates rose ¥1,927 million to ¥32,965 million, which on the arithmetic of the two figures is 59.8% of the group's assets. Investment securities added ¥252 million to ¥11,284 million. Current assets fell 7.4% to ¥7,970 million as money held in trust dropped ¥600 million, receivables ¥228 million and work in process ¥171 million, while cash and deposits rose ¥309 million to ¥2,551 million. Liabilities remain small — ¥5,854 million against ¥49,287 million of net assets, for an equity ratio of 89.3% against 89.7% three months earlier — and within them short-term borrowings rose ¥216 million and contract liabilities ¥293 million, against a ¥184 million fall in trade payables. Net assets rose ¥1,105 million, which the company attributes to a ¥479 million increase in the foreign currency translation adjustment, ¥421 million in retained earnings and ¥254 million in net unrealised gains on securities. The 192.0% jump in comprehensive income has the same root as the fall in ordinary profit: other comprehensive income of ¥672 million included the group's share of its equity-method associates' own other comprehensive income at positive ¥440 million, against negative ¥1,061 million a year earlier, when that item alone had pulled comprehensive income down to ¥744 million.

Four segments, and the two that grew are the small ones

The segment note is stated in thousands of yen while the summary tables are in millions, so the two must be read against each other with care. Global Data Intelligence, the Cellebrite-centred business, grew revenue 35.8% to ¥387 million and segment profit 51.1% to ¥34 million on sales of Cellebrite products and a rising number of subscription contracts; it is the smallest revenue line, about 15% of external sales. Entertainment is still the bulk of the trading at ¥1,476 million, roughly 57% of external sales, but fell 16.9% and its profit 22.2% to ¥156 million: shipment volumes of pachinko and pachislot machine parts dropped, though the company says cost reduction lifted that sub-business's profit, while the game content business released no new titles and spent more on development, so it fell on both lines. IT grew revenue 35.7% to ¥717 million and swung from a ¥13 million segment loss to a ¥67 million segment profit: the prior year had been depressed by the tailing-off of the migration to LTE that followed the carriers' 3G shutdowns, that drag has cleared, selling prices were revised to pass on rising costs, and the consolidated subsidiary EKTech group grew sales steadily in Malaysia. The segment was renamed from "New IT" to "IT" in the previous interim period, with no effect on the figures. Wellness, run through the consolidated subsidiary Sun Digital Health (サンデジタルヘルス株式会社), still records no revenue at all and its loss widened to ¥7 million from ¥1 million while it prepares the Japanese launch of products from MyWaves Technologies, a sleep-technology company. The four segments together earned ¥251 million of profit against ¥208 million a year earlier, and unallocated corporate overhead and intersegment eliminations of −¥257 million, improved from −¥299 million, bring the total back to the consolidated operating loss of ¥6 million. Those two movements — ¥42 million from the segments and ¥41 million from the adjustment — are the ¥83 million by which the operating loss narrowed.

The full-year guide still needs ¥16,644 million of sales, and the filing does not say where from

Guidance for the year to March 2027 is unchanged from the previously published forecast: net sales of ¥19,222 million (+94.0%), operating profit of ¥2,131 million against an operating loss in FY3/2026, ordinary profit of ¥8,300 million (+61.7%) and profit attributable to owners of the parent of ¥7,600 million (−21.4%). Set against the quarter just reported, the first three months delivered 13.4% of the sales guide, 4.6% of the ordinary-profit guide and 19.7% of the net-profit guide — ratios that follow from dividing one stated figure by the other. The sales line is the largest question. At +94.0% the guide implies an FY3/2026 base of roughly ¥9,900 million, so the year is guided to about double while the first quarter fell 0.3%, and ¥16,644 million of sales still has to arrive in the remaining nine months. This filing does not say where that comes from. It contains no discussion of the forecast beyond the "no revision" flag, and it refers the reader to a separate supplementary presentation for detail on the consolidated results — a document that is not part of the tanshin. The composition of the guide should be treated as undisclosed here rather than inferred.

The dividend is undecided, and two accounting changes are called immaterial

The FY3/2027 dividend is undecided. The filing prints no forecast figure for any quarter-end and states that the company is leaving the FY3/2027 dividend forecast undetermined for the time being; no payment start date is given. For FY3/2026 the company paid ¥50.00 per share, all of it at the year-end, with ¥0.00 at the half-year. Earnings per share fell 12.6% against a 15.5% fall in attributable profit, because the average number of shares outstanding during the quarter fell to 21,519,041 from 22,269,478; shares issued were unchanged at 24,007,728 and treasury shares edged down to 2,479,700 from 2,489,816. Two accounting-policy changes were flagged on the cover, and the company describes the effect of both as slight. The first applies the revised practical guidelines on accounting for financial instruments (Transfer Guidance No. 9, dated March 11, 2025) from the start of this quarter, so that shares without a market price held among the assets of partnerships and similar vehicles — excluding the company's own subsidiaries and affiliates — are measured at fair value as the basis for accounting for those interests; the transitional treatment of paragraph 205-2 was followed. The second changes how tax expense is computed at the parent and some subsidiaries, from the principled method to applying a reasonably estimated annual effective rate to pre-tax quarterly profit, adopted to make the quarterly close more efficient and not applied retrospectively because the effect is immaterial. No quarterly consolidated cash flow statement was prepared — depreciation was ¥52 million, goodwill amortisation ¥16 million and customer-related asset amortisation ¥2 million — the statements were not reviewed by an accounting auditor, and the filing reports no significant subsequent events.

JapanStockPulse provides informational content only and does not constitute investment advice. Figures are taken from the company's published earnings short report and may be subject to subsequent revision.